Product Portfolio header Spectrum Pharmaceuticals Product Portfolio picture
   
Oncology, Generics, Neurology Drugs About Spectrum Pharmaceuticals SPPI Investor Relations SPPI News
shadow area

SPI-205

A lipid suspension of leteprinim

SPI-205 Target Indication
  • Chemotherapy-induced neuropathy

Route of Administration
  • Intramuscular injection

SPI-205 Mode of Action

Animal data is suggestive of:
  • Neuroprotective and nerve sprouting effects mediated through several nerve growth factors
  • Benefits in chemotherapy-induced neuropathy in experimental models
SPI-205

SPI-205 Status
  • Preclinical

Advanced Search  |  Home  |  Site Map  |  Contact Us  |  WebMail

 All contents © Copyright Spectrum Pharmaceuticals, Inc. 2008. All Rights Reserved.  Terms of Use